El-Azzouni MZ - Search Results

1

Schistosomiasis mansoni: A new therapeutic target for ubiquinol, a natural inhibitor of neutral magnesium-dependent sphingomyelinase in murine model.

Amer EI, El-Azzouni MZ, El-Bannan RT, Shalaby TI, El-Achy SN, Gomaa MM. Amer EI, et al. Among authors: el azzouni mz. Acta Trop. 2022 Feb;226:106231. doi: 10.1016/j.actatropica.2021.106231. Epub 2021 Nov 14. Acta Trop. 2022. PMID: 34785184

2

Miltefosine, a promising novel agent for schistosomiasis mansoni.

Eissa MM, El-Azzouni MZ, Amer EI, Baddour NM. Eissa MM, et al. Int J Parasitol. 2011 Feb;41(2):235-42. doi: 10.1016/j.ijpara.2010.09.010. Epub 2010 Nov 3. Int J Parasitol. 2011. PMID: 21055404

3

Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.

Eissa MM, El-Moslemany RM, Ramadan AA, Amer EI, El-Azzouni MZ, El-Khordagui LK. Eissa MM, et al. Among authors: el azzouni mz. PLoS One. 2015 Nov 17;10(11):e0141788. doi: 10.1371/journal.pone.0141788. eCollection 2015. PLoS One. 2015. PMID: 26574746 Free PMC article.

4

Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.

El-Faham MH, Eissa MM, Igetei JE, Amer EI, Liddell S, El-Azzouni MZ, Doenhoff MJ. El-Faham MH, et al. Among authors: el azzouni mz. PLoS Negl Trop Dis. 2017 Aug 25;11(8):e0005853. doi: 10.1371/journal.pntd.0005853. eCollection 2017 Aug. PLoS Negl Trop Dis. 2017. PMID: 28841653 Free PMC article.

5

Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.

El-Moslemany RM, Eissa MM, Ramadan AA, El-Khordagui LK, El-Azzouni MZ. El-Moslemany RM, et al. Among authors: el azzouni mz. Acta Trop. 2016 Jul;159:142-8. doi: 10.1016/j.actatropica.2016.03.038. Epub 2016 Mar 31. Acta Trop. 2016. PMID: 27039667

6

Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.

Eissa MM, El-Azzouni MZ, El-Khordagui LK, Abdel Bary A, El-Moslemany RM, Abdel Salam SA. Eissa MM, et al. Among authors: el azzouni mz. Acta Trop. 2020 Dec;212:105714. doi: 10.1016/j.actatropica.2020.105714. Epub 2020 Sep 17. Acta Trop. 2020. PMID: 32950482

7

Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.

Eissa MM, El-Azzouni MZ, El-Khordagui LK, Abdel Bary A, El-Moslemany RM, Abdel Salam SA. Eissa MM, et al. Among authors: el azzouni mz. Parasit Vectors. 2020 Sep 15;13(1):474. doi: 10.1186/s13071-020-04346-1. Parasit Vectors. 2020. PMID: 32933556 Free PMC article.

8

Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer.

Eissa MM, Ismail CA, El-Azzouni MZ, Ghazy AA, Hadi MA. Eissa MM, et al. Among authors: el azzouni mz. Invest New Drugs. 2019 Feb;37(1):47-56. doi: 10.1007/s10637-018-0609-6. Epub 2018 May 28. Invest New Drugs. 2019. PMID: 29808307

9

Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting.

Amara RO, Ramadan AA, El-Moslemany RM, Eissa MM, El-Azzouni MZ, El-Khordagui LK. Amara RO, et al. Among authors: el azzouni mz. Int J Nanomedicine. 2018 Aug 6;13:4493-4505. doi: 10.2147/IJN.S167285. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30122922 Free PMC article.

10

Maternal transfer of resistance to Schistosoma mansoni in offspring born to Trichinella-infected mice.

el-Mansoury ST, el-Azzouni MZ, Gendi HA. el-Mansoury ST, et al. J Egypt Soc Parasitol. 1992 Apr;22(1):153-60. J Egypt Soc Parasitol. 1992. PMID: 1578161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters